$OTLK
Outlook Therapeutics, Inc. Common Stock
XNAS•Health Care•Biological Products, (No Diagnostic Substances)
$0.678
▼-0.48%-$0.003
Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonateOutlook Therapeutics, Inc. Common Stock
XNAS•Health Care•Biological Products, (No Diagnostic Substances)
Why is OTLK down today? It is at $0.678 (-0.48%), and our scanner flagged it 79 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment OTLK spikes, and full due diligence on OTLK — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $OTLK 79 times in the last 30 days. Create a free account to track $OTLK, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Here is the latest on OTLK from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for OTLK today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Kenyon Lawrence A Officer | Acquired (grant/award) | +101K 0.04% of company | added 100% | 107K | n/a | Aug 14, 26 |
Jahr Robert Charles Officer | Acquired (grant/award) | +152K 0.06% of company | n/a | 152K | n/a | Aug 14, 26 |
Sukhtian Ghiath M. Director | Bought (open market) | +2.53M 1.0% of company | added 11% | 24.62M | $2.5M at $0.990 | Aug 12, 26 |
Sukhtian Faisal Ghiath Director | Bought (open market) | +95K 0.04% of company | added 76% | 221K | $100K at $1.05 | Jul 29, 26 |
Haddadin Yezan Munther Director | Bought (open market) | +29K 0.01% of company | added 78% | 66K | $24K at $0.830 | Jun 2, 26 |
Sukhtian Ghiath M. Director | Bought (open market) | +8.54M 3.5% of company | added 63% | 22.09M | $5.0M at $0.590 | May 28, 26 |
Sukhtian Faisal Ghiath Director | Bought (open market) | +122K 0.05% of company | added 100% | 126K | $50K at $0.410 | May 27, 26 |
Hilzinger Kurt J Director | Bought (open market) | +400K 0.2% of company | added 100% | 424K | $176K at $0.440 | May 26, 26 |
Thurman Randy H Director | Bought (open market) | +5K | added 100% | 6K | $2K at $0.430 | May 26, 26 |
Haddadin Yezan Munther Director | Bought (open market) | +34K 0.01% of company | added 100% | 37K | $15K at $0.440 | May 26, 26 |
Sukhtian Ghiath M. Director | Acquired (grant/award) | +4.29M 1.8% of company | added 46% | 13.55M | $6.0M at $1.40 | May 27, 25 |
Kenyon Lawrence A Officer | Bought (open market) | +5K | added 100% | 6K | $28K at $5.69 | Sep 26, 24 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
Comparable names in biological products, (no diagnostic substances), closest in size first.
Here is the latest on OTLK from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for OTLK today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
OTLK last traded at $0.678, down 0.48% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
The OTLK Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged OTLK 79 times in the last 30 days.
OTLK (Outlook Therapeutics, Inc. Common Stock) trades on XNAS, with a market cap of about $159M in the Biological Products, (No Diagnostic Substances) sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge OTLK for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$OTLK discussion
Sign in to ask a question or join the discussion.